The Johns Hopkins Brady Urological Institute
The Johns Hopkins Brady Urological Institute is proud to offer the first MRI-guided TULSA (Transurethral Ultrasound Ablation) Program in the Baltimore/Washington, DC region, providing an incision-free treatment option for patients with prostate cancer and benign prostatic hyperplasia (BPH).
The Johns Hopkins Brady Urological Institute is recognized as one of the premier urological centers in the world and home to many of the most accomplished experts in urologic medicine. Our team collaborates closely with specialists in oncology, pediatrics, nephrology, and other disciplines across Johns Hopkins to deliver personalized treatment plans and exceptional, research-driven care.
The Johns Hopkins Hospital and Brady Urological Institute have consistently ranked among the top hospitals and urology programs in the nation by U.S. News & World Report, known for leadership in both clinical care and groundbreaking research in urologic diseases.
Have questions? We're here to help.
If you have questions about the TULSA Procedure, connect with one of our helpful Patient Educators.
Center Address
601 N. Caroline St., 4th Floor, Baltimore, MD 21287
